Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,563 | 54,126 | 26,216 | 53,814 | 108,970 |
| Marketable Securities | 298,225 | 257,221 | 267,864 | 328,628 | 274,729 |
| Receivables | 31,203 | 31,658 | 27,021 | 27,467 | 27,702 |
| Inventories | 40,043 | 41,411 | 39,112 | 33,602 | 30,311 |
| TOTAL | $418,734 | $391,110 | $365,835 | $450,991 | $447,964 |
| Non-Current Assets | |||||
| PPE Net | 109,225 | 107,046 | 105,947 | 103,239 | 102,571 |
| Investments And Advances | 35,829 | 74,193 | 80,807 | 0 | 0 |
| Intangibles | 57,490 | 55,197 | 52,956 | 50,943 | 48,829 |
| Other Non-Current Assets | 759 | 825 | 545 | 572 | 598 |
| TOTAL | $203,303 | $237,261 | $240,255 | $154,754 | $151,998 |
| Total Assets | $622,037 | $628,371 | $606,090 | $605,745 | $599,962 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,913 | 14,658 | 12,278 | 10,392 | 9,373 |
| Accrued Expenses | 33,017 | 41,057 | 39,701 | 46,755 | 34,900 |
| TOTAL | $48,368 | $56,217 | $52,337 | $57,510 | $45,648 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 102 | N/A | N/A | 520 |
| Other Non-Current Liabilities | 295,148 | 292,671 | 288,953 | 287,187 | 276,324 |
| TOTAL | $295,148 | $292,671 | $288,953 | $287,187 | $283,681 |
| Total Liabilities | $343,516 | $348,888 | $341,290 | $344,697 | $329,329 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,732 | 40,712 | 40,570 | 40,342 | 40,094 |
| Common Shares | 41 | 41 | 41 | 40 | 40 |
| Retained earnings | -398,455 | -389,136 | -393,731 | -386,134 | -366,391 |
| Other shareholders' equity | -901 | -454 | -67 | -64 | -82 |
| TOTAL | $278,521 | $279,483 | $264,800 | $261,048 | $270,633 |
| Total Liabilities And Equity | $622,037 | $628,371 | $606,090 | $605,745 | $599,962 |